Franklin Resources
GNCA

Franklin Resources’s Genocea Biosciences, Inc. GNCA Stock Holding History

Franklin Resources’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-374,275
Closed -$15.6M – 1533
2017
Q2 		$15.6M Hold
374,275
– – 0.01% 857
2017
Q1 		$18.2M Hold
374,275
– – 0.01% 809
2016
Q4 		$12.3M Sell
374,275
-3,888
-1% -$128K 0.01% 907
2016
Q3 		$15.5M Hold
378,163
– – 0.01% 869
2016
Q2 		$12.4M Buy
378,163
+17,338
+5% +$636K 0.01% 920
2016
Q1 		$22.3M Buy
360,825
+97,425
+37% +$3.09M 0.01% 786
2015
Q4 		$11.1M Buy
263,400
+135,275
+106% +$6.45M 0.01% 983
2015
Q3 		$7.02M Buy
128,125
+21,875
+21% +$2.17M ﹤0.01% 1086
2015
Q2 		$11.7M Hold
106,250
– – 0.01% 1007
2015
Q1 		$10.1M Buy
+106,250
New +$7.5M ﹤0.01% 1051

Other funds holding GNCA

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

Franklin Resources's GNCA Position: Q3 2017 in Review

Franklin Resources sold out of Genocea Biosciences, Inc. (GNCA) in Q3 2017, closing a stake of 374,275 shares — an estimated $15.6M sold.

Franklin Resources first reported a position in GNCA in Q1 2015 and held it in 10 quarters. The position peaked at $22.3M in Q1 2016. 62 funds tracked by Wall St. Rank hold GNCA as of Q3 2017.

  • Franklin Resources reported no remaining Genocea Biosciences, Inc. position as of Q3 2017 after selling out during the quarter.
  • Franklin Resources sold 374,275 Genocea Biosciences, Inc. shares in Q3 2017, an estimated $15.6M.
  • Franklin Resources first reported a position in Genocea Biosciences, Inc. in Q1 2015 and held it in 10 quarters.
  • Franklin Resources's Genocea Biosciences, Inc. position peaked at $22.3M in Q1 2016.
  • 62 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q3 2017.

Based on Franklin Resources's 13F filing for Q3 2017, filed 13 Nov 2017.